How much does eliminating one or two cardiovascular risk factors matter?: Evidence from the Global Cardiovascular

Roberto Spoladore1, Stefano Pedroli1,2, Andrea Tacchetto1,2

  • 1Division of Cardiology, Alessandro Manzoni Hospital, Lecco, Italy.

Insights

Eliminating hypertension and smoking significantly boosts life expectancy and reduces cardiovascular disease risk. Even without these factors, some residual risk remains, highlighting the complexity of cardiovascular health.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Five key modifiable risk factors (hypertension, diabetes, smoking, hypercholesterolemia, obesity) contribute to 50% of the global cardiovascular disease burden.
  • Recent research indicates that absence of diabetes and smoking is linked to optimal life expectancy and cardiovascular disease-free years.

Purpose of the Study:

  • To analyze the impact of modifiable cardiovascular risk factors on life expectancy and years lived free from cardiovascular disease.
  • To identify the most influential risk factors and their combined effects on longevity and healthspan.

Main Methods:

  • Utilized data from the Global Cardiovascular Risk Consortium.
  • Analyzed associations between five modifiable risk factors (hypertension, diabetes, smoking, hypercholesterolemia, obesity) and cardiovascular outcomes.
  • Assessed the impact of eliminating risk factors at midlife on life expectancy and all-cause mortality.

Main Results:

  • Absence of diabetes and smoking correlates with the lowest cardiovascular risk and highest life expectancy.
  • Lower systolic blood pressure (<130 mmHg), reduced non-HDL cholesterol, and normal body weight are associated with later disease onset and modest life expectancy gains.
  • Eliminating hypertension and smoking in midlife yields the greatest increase in years lived free from cardiovascular disease and all-cause mortality.
  • Male sex is a non-modifiable risk factor, and a residual risk of cardiovascular disease exists even in the absence of all considered modifiable factors.

Conclusions:

  • Controlling modifiable risk factors, particularly hypertension and smoking, is crucial for extending life and improving cardiovascular health.
  • While eliminating major risk factors significantly enhances longevity, a residual lifetime risk for cardiovascular disease persists.
  • Public health strategies should focus on comprehensive risk factor management to maximize cardiovascular health and longevity.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...